Recent evidence revealed that presentation of soluble antigens is governed by the endocytosis mechanisms that determine the intracellular routing of the endocytosed antigens. Soluble antigens intended for classical exogenous MHC-II-restricted presentation are internalized into lysosomes. Soluble antigens destined for crosspresentation are taken up by distinct endocytosis mechanisms and are conveyed into stable early endosomes. Particulate antigens enter phagosomes, in which both MHC-I-restricted and MHC-II-restricted presentation is initiated. In this review, we discuss the mechanistical differences in presentation of soluble and particulate antigen, the correlation of various endocytic receptors with antigen routing and presentation, the differential expression of these receptors in antigen-presenting cell subsets with respect to their ability to crosspresent, and implications on the molecular mechanisms controlling cross-presentation. 
Introduction
The traditional view of antigen presentation stated that intracellularly synthesized antigens, for example of viral or tumor origin, are presented by MHC I molecules and activate CD8 + cytotoxic T cells, whereas extracellular antigens are presented by professional antigen-presenting cells (APCs) with MHC II molecules to CD4 + T helper cells. To this end, extracellular antigens are internalized into specialized organelles, which are termed phagosomes in case of cell-associated antigens, and endosomes for soluble antigens. Both compartments subsequently mature and undergo a series of molecular changes, such as acidification and fusion with organelles containing degrading enzymes, in particular lysosomes. In late endosomes/lysosomes, antigenic peptides can be generated and loaded onto MHC II molecules, followed by transport of these complexes to the cell surface for presentation to CD4 + T cells.
Crosspresentation denotes the MHC-I-restricted presentation of extracellular antigens. The existence of this process has long been controversial, though the necessity of professional APCs for activation also of CD8 + T cells clearly implies the requirement of crosspresentation for immunity against viruses that do not infect APCs, or against tumors derived from non-APCs. Before substantial evidence for crosspresentation had become available, the assumption that extracellular antigen was presented exclusively to CD4 + T cells had implied that the different mechanisms of endocytosis (phagocytosis for particulate antigens, receptor-mediated endocytosis and pinocytosis for soluble antigens) supplied only MHC-II-restricted antigen presentation. Thus, a differential influence of these mechanisms on antigen presentation, in particular on crosspresentation, had not been an obvious question to be experimentally addressed. Here, we discuss associations between endocytosis receptors, target organelles, DC subtypes, and T cell activation that shed new light on the mechanisms governing antigen presentation.
Presentation of particulate antigens is time-dependent
Particulate antigens are internalized into phagosomes, from where processing for presentation on MHC I and MHC II molecules is initiated. Recent studies have demonstrated that active alkalization of the phagosome by the NADPH oxidase NOX2 is required for crosspresentation [1 ] . This alkalization prevented activation of lysosomal proteases, so that internalized particulate antigens were rescued from rapid degradation and remained available for loading onto MHC I [2 ] . Such crosspresentation involved export from the phagosome into the cytoplasm for proteasomal processing [3] , and TAP-dependent import of resulting peptides into the compartment where they are loaded onto MHC I molecules, which has been proposed to be the same phagosome [4] [5] [6] .
However, active alkalization of phagosomes was transient. After some time when antigens could be processed for crosspresentation, ROS production ceased, resulting in phagosome acidification and activation of lysosomal proteases [7] . This permitted generation of peptides from particulate antigens within the phagosome, which then could be loaded onto MHC II molecules [8] . Hence, MHC-I-restricted and MHC-II-restricted presentation of particulate antigens occur sequentially: first, crosspresentation occurs at mildly acidic intraphagosomal pH, followed by loading onto MHC II molecules at more acidic pH (Figure 1 ).
Presentation of soluble antigens is localization-dependent
Presentation of soluble antigens is assumed to be regulated by mechanisms similar to those governing presentation of particulate antigens. Consequently, soluble antigens are thought to be targeted toward a common pool of endosomes, which matured toward late endosomes and fused with lysosomes, in which peptides for MHC-II-restricted presentation can be generated [8] . Antigens intended for crosspresentation consequently would have to be diverted from endosomes toward the cytoplasm, to be available for proteasomal degradation into peptides for loading onto MHC I molecules. The mechanisms governing such intracellular antigen sorting are unclear.
It has recently been demonstrated that internalized proteins are not generally entered into a common pool of early endosomes [9 ] , but rather into distinct populations of early endosomes with different maturation kinetics: one matured rapidly into late endosomes and one of them was more stable. Sorting of cargo into these subsets occurred already at the plasma membrane, and was likely because of the association of the endocytic receptor with adaptor proteins. Thus, antigen sorting may be primarily determined by the endocytosis mechanism, which of course does not exclude an additional role of subsequent intracellular sorting from endosomes.
Such endocytosis-dependent routing into different endosomal compartments has recently been shown to be crucially important for antigen presentation [10 ] . Soluble antigen taken up by the mannose receptor (MR) was routed toward a mildly acidic stable early endosomal compartment for exclusive presentation on MHC I molecules. By contrast, pinocytosed and scavenger receptor (SR)-endocytosed antigens were targeted rapidly toward lysosomes, where they were processed only for MHC-II-restricted presentation. These results demonstrated that antigens intended for crosspresentation do not have to be diverted intracellularly from those for MHC II presentation, as they were separated already during endocytosis. Hence, in contrast to the time-dependency of presentation of particulate antigens, presentation of soluble antigens appears to depend on intracellular localization (Figure 1 ).
Endocytic properties of the MR and consequences for antigen presentation
The MR is well established to target antigen to early endosomes, but not to lysosomes [10 ,11-13] . Ligand binding to the MR even prevented fusion of phagosomes with lysosomes [14] . However, this inability for lysosomal antigen targeting seemed to be at conflict with reports describing lysosomal targeting [15] and MHC-IIrestricted presentation of mannosylated antigens [16, 17] . These early studies had used mannan, a mannose polymer, as inhibitor of MR-mediated uptake, because MR-deficient mice had not yet been available. More recent studies revealed that highly mannosylated antigens were not taken up by the MR, but instead by DC-SIGN [18] , which is also inhibited by mannan. However, DC-SIGN targets antigen toward MHC-IIrestricted presentation [19] . Thus, it appears possible that some functions formerly attributed to the MR may have been DC-SIGN-mediated.
A widely used approach for targeting antigen to cell surface receptors is the use of specific antibodies coupled to model antigens. Some studies using this technique reported MHC-II-restricted presentation of MR-targeted model antigens [20] [21] [22] . However, antibody-mediated crosslinking of the MR has been shown to functionally mature DC and to change their cytokine secretion profile [23] . Furthermore, crosslinking of dectin-1, a different lectin receptor with endocytic activity, by the b-glucan polymer, zymosan, resulted in routing into lysosomes, as opposed to monovalent b-glucans, which were targeted to nonlysosomal endosomes [24] . These findings demonstrated that receptor crosslinking can profoundly alter its intracellular routing, providing an alternative explanation for the observed MHC-II-restricted presentation resulting from antibody-mediated MR targeting. Moreover, there is also a circulating soluble form of the MR, which may exert distinct effects on antigen presentation in vivo [25] .
Further endocytosis receptors linked to distinct target organelles and selective antigen presentation
An association with selective MHC-I-restricted or MHC-II-restricted antigen presentation has been described for several receptors. For example, DC-SIGN-targeted antigen toward lysosomes and facilitated activation of CD4 + T cells [19, 26] . Other receptors known to mediate MHC-II-restricted presentation include murine SRs, DEC-205, DCIR2, dectin-1, and MGL [10 ,12,27,28 ,29] . For SRs, DEC-205, and MGL, lysosomal targeting has been demonstrated [10 ,12,29] . SRs and DCIR2 were unable to activate CD8 + T cells [10 ,28 ] . DEC-205 facilitated both CD4 + and CD8 + T cell activation [12, 28 ] . Further examples of receptors that could target both MHC-Iloading and MHC-II-loading include the B cell receptor (BCR) and certain Fc receptors [30, 31] . Langerin is a further receptor linked to CD8 + T cell activation [32] , and its cargo is also excluded from lysosomes [33] . Endo180 and SIGNR1, whose role in antigen presentation is unknown, are examples of further receptors with early endosomal routing [33, 34] . Table 1 summarizes the properties of the receptors discussed in this review. It is possible that these associations are further affected by intrinsic properties of the expressing cell, the nature of the antigenic cargo, or by species-specific receptor variations.
Expression of endocytic receptors on distinct APC subsets
The various APC subtypes are specialized at distinct types of antigen presentation, and especially crosspresentation is tightly restricted [35] . Conventional CD8 + DCs are generally regarded the most proficient crosspresenting APCs, and this has been ascribed to their unique antigen-processing capabilities [28 ] . However, CD8 per se does not seem to be functionally involved in crosspresentation, because also CD8 À DCs [36] [37] [38] [39] , certain macrophages [10 ,40] , B cells [30] , and liversinusoidal endothelial cells [41] could do so under certain circumstances. The regulated expression of endocytic receptors linked to crosspresentation offers a mechanistic explanation for these ostensibly conflicting findings. It would also be consistent with the recent demonstration that capturing large antigen amounts is insufficient for crosspresentation [42 ] . Future studies have to determine the relative importance of selective receptor expression [10 ] and processing capabilities [28 ] in MHC-I-restricted and MHC-II-restricted antigen presentation. [10 ] , and DC-SIGN, whose murine equivalent is also known as CIRE [26] , are primarily expressed on CD8 À DCs that cannot crosspresent (Table 2) , consistent with selective antigen introduction into the MHC-II-loading compartment(s).
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DEC-205 is distinguished by its ability to introduce antigen into both the MHC-I-loading and MHC-II-loading compartments. This capability may be important for crosspriming, that is, the immunogenic activation of CD8 + T cells by crosspresentation, because specific CD4 + T cell help is required to 'license' DCs for crosspriming [44] . Thus, the same DC must present antigen to specific CD4 + and CD8 + T cells, and consequently it must capture and introduce antigen into both the MHC-Iloading and MHC-II-loading compartments. In addition to DEC-205, this is the case also for Fc receptors, and may support their ability to recognize antibody-opsonized antigen for efficient T cell priming. For antigens that do not bind to receptors targeting both compartments, either binding to two receptors with overlapping specificity and distinct routing properties would be required. Alternatively, crosspresenting DC may use pinocytosis to obtain antigen for MHC-II-restricted presentation [10 ] . This avoids situation in which a crosspresenting DC that has captured antigen for CD8 + T cell activation, lacks a suitable receptor for cognate presentation to licensing CD4 + T cells.
Loading of antigenic peptide on MHC I molecules
Stable early endosomes have recently been described as compartments that simultaneously contained antigens intended for crosspresentation and crosspresented antigen, that is, antigen-derived peptides loaded onto MHC I molecules [10 ] . This colocalization shed new light on the longstanding question regarding the identity of the elusive organelle of crosspresentation. At least three mechanistic explanations can theoretically account for this observation (Figure 2) . First, antigens could be degraded by endosomal proteases, for example, cathepsins and subsequently be loaded onto MHC I molecules within endosomes (Figure 2a) , which has been referred to as TAPindependent crosspresentation [45, 46] . However, most studies examining the cell biology of crosspresentation reported a requirement of TAP and the proteasome [3-6,10 ,47 ,48,49] . Nevertheless, TAP-independent crosspresentation may play a role for some antigens or antigenic epitopes. A second possibility involves antigen transport into the cytoplasm, degradation by the cytoplasmic proteasome, and reimport of antigen-derived peptides by TAP into the ER (Figure 2b) , which contains the machinery for MHC I loading [50] . From the ER, MHC I/peptide complexes could be transported either toward the early endosomal compartment (where they colocalized with antigen as observed [10 ] ) and from there toward the cell membrane. Alternatively, they could be transported from the ER directly to the cell membrane, in which case subsequent internalization of these complexes would have to be proposed to explain their detection in early endosomes [10 ] . Third, antigen-derived peptides might be reimported from the cytoplasm into early endosomes, and MHC I loading might occur there (Figure 2c ). This of course would require the presence of the MHC-I-loading machinery in these endosomes, which is supported by the detection of calnexin in OVA-containing 'ER-like structures', which were of endosomal morphology and spatially separated from the perinuclear ER [6] . This latter mechanism is reminiscent of that proposed for crosspresentation of particulate antigens [4] [5] [6] , which involved antigen export from phagosomes, cytoplasmic processing by the proteasome, and reimport of peptides into phagosomes by TAP in the phagosomal membrane. Further support for the third mechanism came from a study showing that deficiency of ERAP1, which is involved in endogenous peptide loading in the ER, did not affect crosspresentation of soluble antigen, suggesting that this process may not take place in the ER [49] . The recent identification of endocytosis mechanisms and organelles dedicated to crosspresentation may permit clarifying which of these three mechanisms is relevant.
Finally, it needs to be mentioned that additional mechanisms for crosspresentation have been described. Thus, 92 Antigen Processing and Recognition antigen-derived peptides from donor cells can directly enter the cytosol of DC by intercellular exchange through GAP junctions [51] . Furthermore, exogenously added b2-microglobulin, a component of the MHC I complex, has been shown to directly enter the ER by unknown routes [52] . Such routing may allow crosspresentation by utilizing the processing mechanisms for endogenous antigens. It remains to be clarified whether ER access is generally possible, or only applies to a subset of antigens.
Conclusions
The endocytosis mechanisms can predetermine intracellular antigen routing, processing, and presentation to CD4 + and/or CD8 + T cells. Pinocytosis and certain receptors, for example, DC-SIGN, DCIR2, or SRs, target antigen toward acidic late endosomes/lysosomes, and thus for MHC-II-restricted antigen presentation. By contrast, the MR, and perhaps also other receptors, can convey antigen into distinct early endosomes that neither mature, acidify, nor fuse with lysosomes, but instead remain stable over extended periods within APCs. Such antigen is exclusively used for crosspresentation. Thus, only MHC-II-restricted antigen presentation requires antigen transport into lysosomes. This model of antigen presentation is consistent with the selective expression of distinct lectin endocytosis receptors on crosspresenting or non-crosspresenting DCs, and may apply also to other APC classes. By contrast, cell-associated antigen is routed into phagosomes, which facilitate both MHC-Irestricted and MHC-II-restricted presentation, albeit at different maturation stages. Crosspresentation of soluble and cell-associated antigen is governed by distinct mechanisms [48, 49, 52, 53 ]. However, for both soluble and cell-associated antigen, the cell-biological mechanisms of crosspresentation remain unclear. In particular, the elusive crosspresentation organelle remains to be identified. Answering this question not only would advance knowledge on the basic mechanisms of antigen presentation but may also contribute to the design of more effective vaccines.
